A New Treatment Option for Severe COPD/Emphysema Endobronchial Valve Therapy (2024 AC LIVE)

Only available as part of a package

Learning Objectives:

Be able to define the pathophysiology of what Endobronchial Valves treat.
Describe the risks of endobronchial valve therapy.
Understand that Endobronchial valve therapy is an established therapy for patients with emphysema included in global guidance of the treatment of COPD

David H. Lindner, DO, MBA, FCCP, FACOI (he/him/his)

Section Chair, Pulmonary & Critical Care

NCH Health Care

Chair Pulmonary Critical Care, Associate Professor: Medicine Mayo Clinic School of Medicine, University Central Florida, Associate Program Director: Pulmonary & Critical Care Fellowships NCH
NCH Physician Group Naples Community Hospital
Naples, Florida, United States

David Harrison Lindner DO MBA FCCP FACOI is Division Chair of Pulmonary Critical Care and Sleep Medicine at Naples Community Hospital. Academic Positions: Instructor Medicine Mayo Clinic School of Medicine, Associate Professor of Medicine University of Central Florida, and Adjunct Associate Professor Nova Southeastern University. Associate Program Director Pulmonary and Critical Care Fellowship NCH Healthcare, and the Critical Care Fellowship NCH healthcare. I am the medical director of the ICU and Respiratory Care.

Dr. Lindner graduated from the Des Moines University and did his Internship at Oakland General Hospital in Detroit, completing his Internal Medicine Residence with the COGMET program via Michigan State University. Subsequent terminal Pulmonary Fellowship at St John's/Oakland General in Detroit and then a Critical Care Fellowship at St. Louis University/St. John's Hospital in St. Louis. He then entered practice in Naples Florida in 1995, and completed a MBA at Auburn University in 2009. His time at NCH Healthcare a two hospital 715 bed facility has seen the development of a full academic program with 60+ residents, and 5 fellowship programs. He is the Associate Program Director of the Pulmonary Critical Care Fellowship and the Critical Care Fellowship. He is a Physician of the Year Nominee in 2010 and Physician of the Year in 2020 as well as a recipient of the Carl Liebert Award for Quality in 2020. Numerous Patient's Choice Awards and Crystal Angel Award winner. He regularly is a speaker both regionally and nationally as well as internationally in Pulmonary & Critical Care.

His current focus and research are in Interventional Pulmonary Medicine, Pulmonary Hypertension and Atypical Mycobacterial Lung Disease. He has served as the subsection head ACOI for Pulmonary & Critical Care Medicine and on the ACOI Research Committee and has been a repeat lecturer at the ACOI national convention.